Evidence map›Paper›PMID 22864146›Full record

ArticleVaccine2012

Oral vaccination with vaccinia virus expressing the tick antigen subolesin inhibits tick feeding and transmission of Borrelia burgdorferi.

Mekki Bensaci, Debaditya Bhattacharya, Roger Clark, Linden T Hu

Abstract read
In one paragraph

Article in Vaccine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 62 citations in OpenAlex.

  1. Protective Immunity and New Vaccines for Lyme Disease.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Trial
  2. Article
  3. Article
  4. Evolution of tick vaccinology.Parasitology · 2024
    Review
  5. Review
  6. Universal Tick Vaccines: Candidates and Remaining Challenges.Animals : an open access journal from MDPI · 2023
    Review
  7. Tick saliva and its role in pathogen transmission.Wiener klinische Wochenschrift · 2023
    Article
  8. Review
  9. Article
  10. Identification of microRNAs in the Lyme Disease VectorInternational journal of molecular sciences · 2022
    Article
  11. Review
  12. Review
  13. Interactions Between Ticks and Lyme Disease Spirochetes.Current issues in molecular biology · 2021
    Article
  14. Interactions between Borrelia burgdorferi and ticks.Nature reviews. Microbiology · 2020
    Review
  15. Article
  16. Review
  17. Novel targets and strategies to combat borreliosis.Applied microbiology and biotechnology · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mekki BensaciDivision of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA 02111, USA.
Debaditya Bhattacharya
Roger Clark
Linden T Hu
Tufts Medical Center · USTufts University · US

Funding

Infectious Disease Training-Pathogenesis/Host ResponseT32AI007329 · NIAID · TUFTS MEDICAL CENTER · PI HU, LINDEN T · 1988 to 2018
$4.1M
Development of a multivalent vaccine for mouse reservoirs of deer tick pathogensR01AI068799 · NIAID · TUFTS MEDICAL CENTER · PI HU, LINDEN T · 2009 to 2010
$633k
Delivery system development for a reservoir targeted Lyme disease vaccineR41AI078631 · NIAID · FOODSOURCE LURE CORPORATION · PI HU, LINDEN T · 2008 to 2009
$600k
NIAID NIH HHS R01 AI068799NIAID NIH HHS R01AI068799NIAID NIH HHS R41 AI078631NIAID NIH HHS R41AI078631NIAID NIH HHS T32 AI007329
6 · The paper itself

Abstract

Immunization with the Ixodes scapularis protein, subolesin, has previously been shown to protect hosts against tick infestation and to decrease acquisition of Anaplsma marginale and Babesia bigemina. Here we report the efficacy of subolesin, a conserved tick protein that can act as a regulator of gene expression, expressed from vaccinia virus for use as an orally delivered reservoir - targeted vaccine for prevention of tick infestation and acquisition/transmission of Borrelia burgdorferi to its tick and mouse hosts. We cloned subolesin into vaccinia virus and showed that it is expressed from mammalian cells infected with the recombinant virus in vitro. We then vaccinated mice by oral gavage. A single dose of the vaccine was sufficient for mice to generate antibody response to subolesin. Vaccination with the subolesin expressing vaccinia virus inhibited tick infestation by 52% compared to control vaccination with vaccinia virus and reduced uptake of B. burgdorferi among the surviving ticks that fed to repletion by 34%. There was a reduction in transmission of B. burgdorferi to uninfected vaccinated mice of 40% compared to controls. These results suggest that subolesin has potential as a component of a reservoir targeted vaccine to decrease B. burgdorferi, Babesia and Anaplasma species infections in their natural hosts.

Indexed as

AnimalsAntibodies, BacterialAntigensArthropod ProteinsBacterial VaccinesBorrelia burgdorferiFemaleIxodesLyme DiseaseMiceMice, Inbred C3HRecombinant ProteinsTick InfestationsVaccinationVaccinia virusAntibodies, BacterialAntigensArthropod ProteinsBacterial VaccinesRecombinant Proteinssubolesin, tick

Identifiers

PMID22864146
PMCPMC3938954
OpenAlexW2065173800

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.